Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy

by Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean-Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard, John De Vos, Emmanuelle Tchernonog, Laura Platon, Xavier Ayrignac, Patrice Ceballos, Anne Sirvent, Mickael François, Hanane Guedon, Philippe Quittet, Cedric Mongellaz, Aurélie Conte, Charles Herbaux, Caroline Bret, Naomi Taylor, Valérie Dardalhon, Guillaume Cartron
Published 2021-08-01